What obstacles stand in the way of faster development and launch of innovative new medicines and how can they be overcome?
- In: Breaking down barriers to patient access - How to bring stakeholders together on Wednesday, 5 September 2018, 14:30-17:30
- At: Glasgow (Scotland) (2018)
- Type: Presentation
- By: SCHULZE, Hermann (Mallinckrodt Pharmaceuticals Ltd, Switzerland)
- Abstract:
Fast access of innovative medicines is not only of big interest of patients – it is also of big interest of the pharmaceutical industry. Drug development and obtaining marketing authorizations are the time-limiting hurdles to pass before medicines become available to patients. Drug development and drug approval can easily take 10 years. And the
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023